APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lysosomal Alpha Glucosidase

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Lysosomal Alpha Glucosidase Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025192 pages

Choose your research edition.

Industry ResearchLysosomal Alpha Glucosidase Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Lysosomal Alpha Glucosidase Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Lysosomal Alpha Glucosidase Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lysosomal Alpha Glucosidase Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Lysosomal Alpha Glucosidase Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Lysosomal Alpha Glucosidase market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Lysosomal Alpha Glucosidase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Lysosomal Alpha Glucosidase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Lysosomal Alpha Glucosidase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Lysosomal Alpha Glucosidase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Lysosomal Alpha Glucosidase include Sarepta Therapeutics Inc, Pharming Group NV, Oxyrane Belgium NV, JCR Pharmaceuticals Co Ltd, Huons Co Ltd, greenovation Biotech GmbH, Genzyme Corp, Etubics Corp and Audentes Therapeutics Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Lysosomal Alpha Glucosidase market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Lysosomal Alpha Glucosidase and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Lysosomal Alpha Glucosidase sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Lysosomal Alpha Glucosidase market size, projected growth trends, production technologies, key applications, and end-use industries.

Lysosomal Alpha Glucosidase Segment by Company

Sarepta Therapeutics Inc

Pharming Group NV

Oxyrane Belgium NV

JCR Pharmaceuticals Co Ltd

Huons Co Ltd

greenovation Biotech GmbH

Genzyme Corp

Etubics Corp

Audentes Therapeutics Inc

Amicus Therapeutics Inc

Lysosomal Alpha Glucosidase Segment by Type

AT-982

ATB-200

AVRRD-03

JR-162

MOSS-GAA

OXY-2810

Others

Lysosomal Alpha Glucosidase Segment by Application

Glycogen Storage Disease

Pompe Disease

Others

Lysosomal Alpha Glucosidase Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lysosomal Alpha Glucosidase market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lysosomal Alpha Glucosidase and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lysosomal Alpha Glucosidase.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Lysosomal Alpha Glucosidase market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Lysosomal Alpha Glucosidase manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Lysosomal Alpha Glucosidase in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Lysosomal Alpha Glucosidase in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Lysosomal Alpha Glucosidase Industry Trends Table 2. Lysosomal Alpha Glucosidase Industry Drivers Table 3. Lysosomal Alpha Glucosidase Industry Opportunities and Challenges Table 4. Lysosomal Alpha Glucosidase Industry Restraints Table 5. Global Lysosomal Alpha Glucosidase Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Lysosomal Alpha Glucosidase Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Lysosomal Alpha Glucosidase Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Lysosomal Alpha Glucosidase Sales Market Share by Manufacturers Table 9. Global Lysosomal Alpha Glucosidase Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Lysosomal Alpha Glucosidase Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Lysosomal Alpha Glucosidase Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Lysosomal Alpha Glucosidase Manufacturers, Product Type & Application Table 13. Global Lysosomal Alpha Glucosidase Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Lysosomal Alpha Glucosidase by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of AT-982 Table 17. Major Manufacturers of ATB-200 Table 18. Major Manufacturers of AVRRD-03 Table 19. Major Manufacturers of JR-162 Table 20. Major Manufacturers of MOSS-GAA Table 21. Major Manufacturers of OXY-2810 Table 22. Major Manufacturers of Others Table 23. Global Lysosomal Alpha Glucosidase Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Lysosomal Alpha Glucosidase Sales by Type (2021-2026) & (K Units) Table 25. Global Lysosomal Alpha Glucosidase Sales by Type (2027-2032) & (K Units) Table 26. Global Lysosomal Alpha Glucosidase Sales Market Share by Type (2021-2026) Table 27. Global Lysosomal Alpha Glucosidase Sales Market Share by Type (2027-2032) Table 28. Global Lysosomal Alpha Glucosidase Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 29. Global Lysosomal Alpha Glucosidase Revenue by Type (2021-2026) & (K Units) Table 30. Global Lysosomal Alpha Glucosidase Revenue by Type (2027-2032) & (K Units) Table 31. Global Lysosomal Alpha Glucosidase Revenue Market Share by Type (2021-2026) Table 32. Global Lysosomal Alpha Glucosidase Revenue Market Share by Type (2027-2032) Table 33. Major Manufacturers of Glycogen Storage Disease Table 34. Major Manufacturers of Pompe Disease Table 35. Major Manufacturers of Others Table 36. Global Lysosomal Alpha Glucosidase Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Lysosomal Alpha Glucosidase Sales by Application (2021-2026) & (K Units) Table 38. Global Lysosomal Alpha Glucosidase Sales by Application (2027-2032) & (K Units) Table 39. Global Lysosomal Alpha Glucosidase Sales Market Share by Application (2021-2026) Table 40. Global Lysosomal Alpha Glucosidase Sales Market Share by Application (2027-2032) Table 41. Global Lysosomal Alpha Glucosidase Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 42. Global Lysosomal Alpha Glucosidase Revenue by Application (2021-2026) & (K Units) Table 43. Global Lysosomal Alpha Glucosidase Revenue by Application (2027-2032) & (K Units) Table 44. Global Lysosomal Alpha Glucosidase Revenue Market Share by Application (2021-2026) Table 45. Global Lysosomal Alpha Glucosidase Revenue Market Share by Application (2027-2032) Table 46. Global Lysosomal Alpha Glucosidase Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 47. Global Lysosomal Alpha Glucosidase Sales by Region (2021-2026) & (K Units) Table 48. Global Lysosomal Alpha Glucosidase Sales Market Share by Region (2021-2026) Table 49. Global Lysosomal Alpha Glucosidase Sales Forecasted by Region (2027-2032) & (K Units) Table 50. Global Lysosomal Alpha Glucosidase Sales Forecasted Market Share by Region (2027-2032) Table 51. North America Lysosomal Alpha Glucosidase Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. North America Lysosomal Alpha Glucosidase Sales by Country (2021-2026) & (K Units) Table 53. North America Lysosomal Alpha Glucosidase Sales by Country (2027-2032) & (K Units) Table 54. Europe Lysosomal Alpha Glucosidase Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Europe Lysosomal Alpha Glucosidase Sales by Country (2021-2026) & (K Units) Table 56. Europe Lysosomal Alpha Glucosidase Sales by Country (2027-2032) & (K Units) Table 57. Asia Pacific Lysosomal Alpha Glucosidase Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Asia Pacific Lysosomal Alpha Glucosidase Sales by Country (2021-2026) & (K Units) Table 59. Asia Pacific Lysosomal Alpha Glucosidase Sales by Country (2027-2032) & (K Units) Table 60. South America, Middle East and Africa Lysosomal Alpha Glucosidase Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 61. South America, Middle East and Africa Lysosomal Alpha Glucosidase Sales by Country (2021-2026) & (K Units) Table 62. South America, Middle East and Africa Lysosomal Alpha Glucosidase Sales by Country (2027-2032) & (K Units) Table 63. Global Lysosomal Alpha Glucosidase Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 64. Global Lysosomal Alpha Glucosidase Revenue by Region (2021-2026) & (US$ Million) Table 65. Global Lysosomal Alpha Glucosidase Revenue by Region (2027-2032) & (US$ Million) Table 66. Global Lysosomal Alpha Glucosidase Revenue Market Share by Region (2021-2026) Table 67. Global Lysosomal Alpha Glucosidase Revenue Market Share by Region (2027-2032) Table 68. Sarepta Therapeutics Inc Company Information Table 69. Sarepta Therapeutics Inc Business Overview Table 70. Sarepta Therapeutics Inc Lysosomal Alpha Glucosidase Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Sarepta Therapeutics Inc Lysosomal Alpha Glucosidase Product Portfolio Table 72. Sarepta Therapeutics Inc Recent Development Table 73. Pharming Group NV Company Information Table 74. Pharming Group NV Business Overview Table 75. Pharming Group NV Lysosomal Alpha Glucosidase Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Pharming Group NV Lysosomal Alpha Glucosidase Product Portfolio Table 77. Pharming Group NV Recent Development Table 78. Oxyrane Belgium NV Company Information Table 79. Oxyrane Belgium NV Business Overview Table 80. Oxyrane Belgium NV Lysosomal Alpha Glucosidase Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Oxyrane Belgium NV Lysosomal Alpha Glucosidase Product Portfolio Table 82. Oxyrane Belgium NV Recent Development Table 83. JCR Pharmaceuticals Co Ltd Company Information Table 84. JCR Pharmaceuticals Co Ltd Business Overview Table 85. JCR Pharmaceuticals Co Ltd Lysosomal Alpha Glucosidase Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. JCR Pharmaceuticals Co Ltd Lysosomal Alpha Glucosidase Product Portfolio Table 87. JCR Pharmaceuticals Co Ltd Recent Development Table 88. Huons Co Ltd Company Information Table 89. Huons Co Ltd Business Overview Table 90. Huons Co Ltd Lysosomal Alpha Glucosidase Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Huons Co Ltd Lysosomal Alpha Glucosidase Product Portfolio Table 92. Huons Co Ltd Recent Development Table 93. greenovation Biotech GmbH Company Information Table 94. greenovation Biotech GmbH Business Overview Table 95. greenovation Biotech GmbH Lysosomal Alpha Glucosidase Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. greenovation Biotech GmbH Lysosomal Alpha Glucosidase Product Portfolio Table 97. greenovation Biotech GmbH Recent Development Table 98. Genzyme Corp Company Information Table 99. Genzyme Corp Business Overview Table 100. Genzyme Corp Lysosomal Alpha Glucosidase Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Genzyme Corp Lysosomal Alpha Glucosidase Product Portfolio Table 102. Genzyme Corp Recent Development Table 103. Etubics Corp Company Information Table 104. Etubics Corp Business Overview Table 105. Etubics Corp Lysosomal Alpha Glucosidase Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Etubics Corp Lysosomal Alpha Glucosidase Product Portfolio Table 107. Etubics Corp Recent Development Table 108. Audentes Therapeutics Inc Company Information Table 109. Audentes Therapeutics Inc Business Overview Table 110. Audentes Therapeutics Inc Lysosomal Alpha Glucosidase Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Audentes Therapeutics Inc Lysosomal Alpha Glucosidase Product Portfolio Table 112. Audentes Therapeutics Inc Recent Development Table 113. Amicus Therapeutics Inc Company Information Table 114. Amicus Therapeutics Inc Business Overview Table 115. Amicus Therapeutics Inc Lysosomal Alpha Glucosidase Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Amicus Therapeutics Inc Lysosomal Alpha Glucosidase Product Portfolio Table 117. Amicus Therapeutics Inc Recent Development Table 118. Key Raw Materials Table 119. Raw Materials Key Suppliers Table 120. Lysosomal Alpha Glucosidase Distributors List Table 121. Lysosomal Alpha Glucosidase Customers List Table 122. Research Programs/Design for This Report Table 123. Authors List of This Report Table 124. Secondary Sources Table 125. Primary Sources List of Figures Figure 1. Lysosomal Alpha Glucosidase Product Image Figure 2. Global Lysosomal Alpha Glucosidase Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lysosomal Alpha Glucosidase Market Size (2021-2032) & (US$ Million) Figure 4. Global Lysosomal Alpha Glucosidase Sales (2021-2032) & (K Units) Figure 5. Global Lysosomal Alpha Glucosidase Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Lysosomal Alpha Glucosidase Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. AT-982 Image Figure 9. ATB-200 Image Figure 10. AVRRD-03 Image Figure 11. JR-162 Image Figure 12. MOSS-GAA Image Figure 13. OXY-2810 Image Figure 14. Others Image Figure 15. Global Lysosomal Alpha Glucosidase Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Lysosomal Alpha Glucosidase Sales Market Share 2021 VS 2025 VS 2032 Figure 17. Global Lysosomal Alpha Glucosidase Sales Market Share by Type (2021-2032) Figure 18. Global Lysosomal Alpha Glucosidase Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 19. Global Lysosomal Alpha Glucosidase Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Lysosomal Alpha Glucosidase Revenue Market Share by Type (2021-2032) Figure 21. Glycogen Storage Disease Image Figure 22. Pompe Disease Image Figure 23. Others Image Figure 24. Global Lysosomal Alpha Glucosidase Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Lysosomal Alpha Glucosidase Sales Market Share 2021 VS 2025 VS 2032 Figure 26. Global Lysosomal Alpha Glucosidase Sales Market Share by Application (2021-2032) Figure 27. Global Lysosomal Alpha Glucosidase Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 28. Global Lysosomal Alpha Glucosidase Revenue Market Share 2021 VS 2025 VS 2032 Figure 29. Global Lysosomal Alpha Glucosidase Revenue Market Share by Application (2021-2032) Figure 30. North America Lysosomal Alpha Glucosidase Sales and Growth Rate (2021-2032) & (K Units) Figure 31. North America Lysosomal Alpha Glucosidase Sales Market Share by Country (2021-2032) Figure 32. U.S. Lysosomal Alpha Glucosidase Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Canada Lysosomal Alpha Glucosidase Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Mexico Lysosomal Alpha Glucosidase Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Europe Lysosomal Alpha Glucosidase Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Europe Lysosomal Alpha Glucosidase Sales Market Share by Country (2021-2032) Figure 37. Germany Lysosomal Alpha Glucosidase Sales and Growth Rate (2021-2032) & (K Units) Figure 38. France Lysosomal Alpha Glucosidase Sales and Growth Rate (2021-2032) & (K Units) Figure 39. U.K. Lysosomal Alpha Glucosidase Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Italy Lysosomal Alpha Glucosidase Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Netherlands Lysosomal Alpha Glucosidase Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Asia Pacific Lysosomal Alpha Glucosidase Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Asia Pacific Lysosomal Alpha Glucosidase Sales Market Share by Country (2021-2032) Figure 44. China Lysosomal Alpha Glucosidase Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Japan Lysosomal Alpha Glucosidase Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South Korea Lysosomal Alpha Glucosidase Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Southeast Asia Lysosomal Alpha Glucosidase Sales and Growth Rate (2021-2032) & (K Units) Figure 48. India Lysosomal Alpha Glucosidase Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Australia Lysosomal Alpha Glucosidase Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South America, Middle East and Africa Lysosomal Alpha Glucosidase Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South America, Middle East and Africa Lysosomal Alpha Glucosidase Sales Market Share by Country (2021-2032) Figure 52. Brazil Lysosomal Alpha Glucosidase Sales and Growth Rate (2021-2032) & (K Units) Figure 53. South Africa Lysosomal Alpha Glucosidase Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Saudi Arabia Lysosomal Alpha Glucosidase Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Turkey Lysosomal Alpha Glucosidase Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Argentina Lysosomal Alpha Glucosidase Sales and Growth Rate (2021-2032) & (K Units) Figure 57. UAE Lysosomal Alpha Glucosidase Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Egypt Lysosomal Alpha Glucosidase Sales and Growth Rate (2021-2032) & (K Units) Figure 59. Chile Lysosomal Alpha Glucosidase Sales and Growth Rate (2021-2032) & (K Units) Figure 60. Global Lysosomal Alpha Glucosidase Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Global Lysosomal Alpha Glucosidase Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 62. North America Lysosomal Alpha Glucosidase Revenue (2021-2032) & (US$ Million) Figure 63. North America Lysosomal Alpha Glucosidase Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Europe Lysosomal Alpha Glucosidase Revenue (2021-2032) & (US$ Million) Figure 65. Europe Lysosomal Alpha Glucosidase Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Asia-Pacific Lysosomal Alpha Glucosidase Revenue (2021-2032) & (US$ Million) Figure 67. Asia-Pacific Lysosomal Alpha Glucosidase Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. South America, Middle East and Africa Lysosomal Alpha Glucosidase Revenue (2021-2032) & (US$ Million) Figure 69. South America, Middle East and Africa Lysosomal Alpha Glucosidase Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. Lysosomal Alpha Glucosidase Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Lysosomal Alpha Glucosidase Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • AT-982
  • ATB-200
  • AVRRD-03
  • JR-162
  • MOSS-GAA
  • OXY-2810
  • Others
Applications
  • Glycogen Storage Disease
  • Pompe Disease
  • Others
Companies covered
  • Sarepta Therapeutics Inc
  • Pharming Group NV
  • Oxyrane Belgium NV
  • JCR Pharmaceuticals Co Ltd
  • Huons Co Ltd
  • greenovation Biotech GmbH
  • Genzyme Corp
  • Etubics Corp
  • Audentes Therapeutics Inc
  • Amicus Therapeutics Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Lysosomal Alpha Glucosidase Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Lysosomal Alpha Glucosidase Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Lysosomal Alpha Glucosidase Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Lysosomal Alpha Glucosidase Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Lysosomal Alpha Glucosidase Market Dynamics
  1. 2.1 Lysosomal Alpha Glucosidase Industry Trends
  2. 2.2 Lysosomal Alpha Glucosidase Industry Drivers
  3. 2.3 Lysosomal Alpha Glucosidase Industry Opportunities and Challenges
  4. 2.4 Lysosomal Alpha Glucosidase Industry Restraints
3 Lysosomal Alpha Glucosidase Market by Manufacturers
  1. 3.1 Global Lysosomal Alpha Glucosidase Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Lysosomal Alpha Glucosidase Sales by Manufacturers (2021-2026)
  3. 3.3 Global Lysosomal Alpha Glucosidase Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Lysosomal Alpha Glucosidase Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Lysosomal Alpha Glucosidase Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Lysosomal Alpha Glucosidase Manufacturers, Product Type & Application
  7. 3.7 Global Lysosomal Alpha Glucosidase Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Lysosomal Alpha Glucosidase Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Lysosomal Alpha Glucosidase Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Lysosomal Alpha Glucosidase Tier 1, Tier 2, and Tier 3
4 Lysosomal Alpha Glucosidase Market by Type
  1. 4.1 Lysosomal Alpha Glucosidase Type Introduction
  2. 4.1.1 AT-982
  3. 4.1.2 ATB-200
  4. 4.1.3 AVRRD-03
  5. 4.1.4 JR-162
  6. 4.1.5 MOSS-GAA
  7. 4.1.6 OXY-2810
  8. 4.1.7 Others
  9. 4.2 Global Lysosomal Alpha Glucosidase Sales by Type
  10. 4.2.1 Global Lysosomal Alpha Glucosidase Sales by Type (2021 VS 2025 VS 2032)
  11. 4.2.2 Global Lysosomal Alpha Glucosidase Sales by Type (2021-2032)
  12. 4.2.3 Global Lysosomal Alpha Glucosidase Sales Market Share by Type (2021-2032)
  13. 4.3 Global Lysosomal Alpha Glucosidase Revenue by Type
  14. 4.3.1 Global Lysosomal Alpha Glucosidase Revenue by Type (2021 VS 2025 VS 2032)
  15. 4.3.2 Global Lysosomal Alpha Glucosidase Revenue by Type (2021-2032)
  16. 4.3.3 Global Lysosomal Alpha Glucosidase Revenue Market Share by Type (2021-2032)
5 Lysosomal Alpha Glucosidase Market by Application
  1. 5.1 Lysosomal Alpha Glucosidase Application Introduction
  2. 5.1.1 Glycogen Storage Disease
  3. 5.1.2 Pompe Disease
  4. 5.1.3 Others
  5. 5.2 Global Lysosomal Alpha Glucosidase Sales by Application
  6. 5.2.1 Global Lysosomal Alpha Glucosidase Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Lysosomal Alpha Glucosidase Sales by Application (2021-2032)
  8. 5.2.3 Global Lysosomal Alpha Glucosidase Sales Market Share by Application (2021-2032)
  9. 5.3 Global Lysosomal Alpha Glucosidase Revenue by Application
  10. 5.3.1 Global Lysosomal Alpha Glucosidase Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Lysosomal Alpha Glucosidase Revenue by Application (2021-2032)
  12. 5.3.3 Global Lysosomal Alpha Glucosidase Revenue Market Share by Application (2021-2032)
6 Global Lysosomal Alpha Glucosidase Sales by Region
  1. 6.1 Global Lysosomal Alpha Glucosidase Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Lysosomal Alpha Glucosidase Sales by Region (2021-2032)
  3. 6.2.1 Global Lysosomal Alpha Glucosidase Sales by Region (2021-2026)
  4. 6.2.2 Global Lysosomal Alpha Glucosidase Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Lysosomal Alpha Glucosidase Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Lysosomal Alpha Glucosidase Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Lysosomal Alpha Glucosidase Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Lysosomal Alpha Glucosidase Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Lysosomal Alpha Glucosidase Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Lysosomal Alpha Glucosidase Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Lysosomal Alpha Glucosidase Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Lysosomal Alpha Glucosidase Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Lysosomal Alpha Glucosidase Revenue by Region
  1. 7.1 Global Lysosomal Alpha Glucosidase Revenue by Region
  2. 7.1.1 Global Lysosomal Alpha Glucosidase Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Lysosomal Alpha Glucosidase Revenue by Region (2021-2026)
  4. 7.1.3 Global Lysosomal Alpha Glucosidase Revenue by Region (2027-2032)
  5. 7.1.4 Global Lysosomal Alpha Glucosidase Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Lysosomal Alpha Glucosidase Revenue (2021-2032)
  8. 7.2.2 North America Lysosomal Alpha Glucosidase Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Lysosomal Alpha Glucosidase Revenue (2021-2032)
  11. 7.3.2 Europe Lysosomal Alpha Glucosidase Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Lysosomal Alpha Glucosidase Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Lysosomal Alpha Glucosidase Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Lysosomal Alpha Glucosidase Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Lysosomal Alpha Glucosidase Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Sarepta Therapeutics Inc
  2. 8.1.1 Sarepta Therapeutics Inc Company Information
  3. 8.1.2 Sarepta Therapeutics Inc Business Overview
  4. 8.1.3 Sarepta Therapeutics Inc Lysosomal Alpha Glucosidase Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sarepta Therapeutics Inc Lysosomal Alpha Glucosidase Product Portfolio
  6. 8.1.5 Sarepta Therapeutics Inc Recent Developments
  7. 8.2 Pharming Group NV
  8. 8.2.1 Pharming Group NV Company Information
  9. 8.2.2 Pharming Group NV Business Overview
  10. 8.2.3 Pharming Group NV Lysosomal Alpha Glucosidase Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Pharming Group NV Lysosomal Alpha Glucosidase Product Portfolio
  12. 8.2.5 Pharming Group NV Recent Developments
  13. 8.3 Oxyrane Belgium NV
  14. 8.3.1 Oxyrane Belgium NV Company Information
  15. 8.3.2 Oxyrane Belgium NV Business Overview
  16. 8.3.3 Oxyrane Belgium NV Lysosomal Alpha Glucosidase Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Oxyrane Belgium NV Lysosomal Alpha Glucosidase Product Portfolio
  18. 8.3.5 Oxyrane Belgium NV Recent Developments
  19. 8.4 JCR Pharmaceuticals Co Ltd
  20. 8.4.1 JCR Pharmaceuticals Co Ltd Company Information
  21. 8.4.2 JCR Pharmaceuticals Co Ltd Business Overview
  22. 8.4.3 JCR Pharmaceuticals Co Ltd Lysosomal Alpha Glucosidase Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 JCR Pharmaceuticals Co Ltd Lysosomal Alpha Glucosidase Product Portfolio
  24. 8.4.5 JCR Pharmaceuticals Co Ltd Recent Developments
  25. 8.5 Huons Co Ltd
  26. 8.5.1 Huons Co Ltd Company Information
  27. 8.5.2 Huons Co Ltd Business Overview
  28. 8.5.3 Huons Co Ltd Lysosomal Alpha Glucosidase Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Huons Co Ltd Lysosomal Alpha Glucosidase Product Portfolio
  30. 8.5.5 Huons Co Ltd Recent Developments
  31. 8.6 greenovation Biotech GmbH
  32. 8.6.1 greenovation Biotech GmbH Company Information
  33. 8.6.2 greenovation Biotech GmbH Business Overview
  34. 8.6.3 greenovation Biotech GmbH Lysosomal Alpha Glucosidase Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 greenovation Biotech GmbH Lysosomal Alpha Glucosidase Product Portfolio
  36. 8.6.5 greenovation Biotech GmbH Recent Developments
  37. 8.7 Genzyme Corp
  38. 8.7.1 Genzyme Corp Company Information
  39. 8.7.2 Genzyme Corp Business Overview
  40. 8.7.3 Genzyme Corp Lysosomal Alpha Glucosidase Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Genzyme Corp Lysosomal Alpha Glucosidase Product Portfolio
  42. 8.7.5 Genzyme Corp Recent Developments
  43. 8.8 Etubics Corp
  44. 8.8.1 Etubics Corp Company Information
  45. 8.8.2 Etubics Corp Business Overview
  46. 8.8.3 Etubics Corp Lysosomal Alpha Glucosidase Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Etubics Corp Lysosomal Alpha Glucosidase Product Portfolio
  48. 8.8.5 Etubics Corp Recent Developments
  49. 8.9 Audentes Therapeutics Inc
  50. 8.9.1 Audentes Therapeutics Inc Company Information
  51. 8.9.2 Audentes Therapeutics Inc Business Overview
  52. 8.9.3 Audentes Therapeutics Inc Lysosomal Alpha Glucosidase Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Audentes Therapeutics Inc Lysosomal Alpha Glucosidase Product Portfolio
  54. 8.9.5 Audentes Therapeutics Inc Recent Developments
  55. 8.10 Amicus Therapeutics Inc
  56. 8.10.1 Amicus Therapeutics Inc Company Information
  57. 8.10.2 Amicus Therapeutics Inc Business Overview
  58. 8.10.3 Amicus Therapeutics Inc Lysosomal Alpha Glucosidase Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Amicus Therapeutics Inc Lysosomal Alpha Glucosidase Product Portfolio
  60. 8.10.5 Amicus Therapeutics Inc Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Lysosomal Alpha Glucosidase Value Chain Analysis
  2. 9.1.1 Lysosomal Alpha Glucosidase Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Lysosomal Alpha Glucosidase Production Mode & Process
  6. 9.2 Lysosomal Alpha Glucosidase Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Lysosomal Alpha Glucosidase Distributors
  9. 9.2.3 Lysosomal Alpha Glucosidase Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst